Forensic Scientists Empowered to Achieve More in the Lab with the Help of Latest Electrophoresis Instruments. FMI Forecasts US$ 3,523.50 million Market Valuation by 2033
NEWARK, Del, Dec. 21, 2023 (GLOBE NEWSWIRE) — The global electrophoresis market value is expected to rise from US$ 2,268.8 million in 2023 to US$ 3,523.50 million by 2033. This estimated growth is expected to be driven by an impressive CAGR of 4.5% in the global electrophoresis market over the next decade.
Increasing demand for capillary electrophoresis instruments to bring efficiencies in the forensic laboratory workflow is propelling the sales of electrophoresis. These systems allow operators to queue new work while another plate is being analyzed.
Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15025
Surging advancements in the speed, precision, and sensitivity of electrophoresis equipment are contributing to its worldwide demand. Additionally, the heightened requirement for innovative drugs and therapies due to the increasing population suffering from chronic diseases is supplementing the sales of electrophoresis. Rising interest in research related to genes, DNA, and proteins is boosting the attractiveness of this market.
The market is predicted to observe a fast-paced startup ecosystem in emerging economies, due to the increasing influx of capital, which is predicted to contribute to increasing research activities and innovation of advanced technologies.
Key players are striving to shave sample processing costs and cost of ownership with consumable pricing. Thus, enhancing the adoption of electrophoresis instruments among end users. For increased revenue from the sales of electrophoresis instruments, key players are forecast to merge, acquire, or partner with other players.
“Rapidly increasing patients suffering from lifestyle and chronic disorders are creating a burden on healthcare systems. Thus, governments are investing in medical research and latest technologies for a robust healthcare setup. To appeal to the masses, key players of electrophoresis are focusing on reducing the cost of these instruments to drive accelerated sales,” says an FMI analyst.
Key Takeaways from the Electrophoresis Market Report:
- The United States is the leading market for electrophoresis, regionally as well as globally. The country is predicted to acquire a market share of 28.6% in 2023.
- Within Europe, Germany is the top contender with a market share of 7% in 2023.
- In Asia Pacific, India is estimated to account for a significant CAGR of 5.9% through 2033.
- Australia is a budding market for electrophoresis. The country is predicted to register a CAGR of 3.8% through 2033.
- Pharma and biotech companies are projected to acquire a share of 27% of the overall electrophoresis market in 2023.
- The reagents and consumables segment is forecast to obtain value share of 48.67% in 2023.
“The Electrophoresis Market demonstrates promising growth potential,” the research manager stated in their published study. “With technological advancements in genetic research and diagnostic procedures, the market is poised to witness a steady expansion” – opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).
Competitive Landscape:
Key Companies Profiled:
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Helena Laboratories Corporation
- Hoefer, Inc. (Harvard Biosciences)
- Merck KGaA
- PerkinElmer Inc.
- SCIEX
- SERVA Electrophoresis GmbH
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Shimadzu Corporation
- Takara Bio, Inc.
- TBG Diagnostic Ltd
- Cleaver Scientific
- QIAGEN N.V.
- Eurogentec
- Sebia Group
- Analytik Jena
- Lonza Group
Purchase the Report for Key Insights: https://www.futuremarketinsights.com/checkout/15025
Key Developments Taking Place in the Electrophoresis Market:
- In October 2022, CMP Scientific Corp. announced that it had inked a co-marketing contract with Agilent Technologies to offer an integrated CE-MS solution to the pharmaceutical and life science industry. The agreement is aimed at the advancement of capillary electrophoresis to offer mass spectrometry solutions.
- In March 2022, Thermo Fisher Scientific launched SeqStudio Flex Series Genetic Analyzer to facilitate cutting-edge research in areas like infectious disease and gene editing. Capillary Electrophoresis (CE), which assists fragment analysis and Sanger sequencing is a critical tool to improve clinical research. The SeqStudio Flex Genetic Analyzer offers superior-quality CE technology with data precision and dependable performance.
- In June 2021, Thermo Fisher Scientific revealed that it has signed a contract with Advanced Electrophoresis Solutions Ltd to boost therapeutic development with the help of cutting-edge protein analysis.
Key Market Segments Covered in Electrophoresis Market Research:
By Product:
- Instruments
- Horizontal Systems
- Vertical Systems
- Capillary Electrophoresis Systems
- Automatic Electrophoresis Systems
- Reagents and Consumables
- Gel
- Polyacrylamide Gel Electrophoresis
- Agarose Gel Electrophoresis
- Others
- Buffers & Others
- Gel
- Software
By End-use Industry:
- Hospitals
- Diagnostic Laboratories
- Pharma & Biotech Companies
- CROs and CMOs
- Academic & Research Institutes
- Forensic Laboratories
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Author by:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage in the Healthcare Domain:
Proteomics Market: Size reached a valuation of US$ 30,825.04 Million in 2022. Increasing adoption of precision medicine and sophisticated diagnostics in specific target disease treatment, as well as the increased concentration of target diseases, are significant drivers of growth prospects.
Testosterone Booster Market: This is expected to reach a valuation of US$ 5,188.1 million in 2024. The market is projected to surge at a CAGR of 6.3% in the estimated period and reach a valuation of US$ 9,083.9 million in 2034.
Vitamin B Test Market: This is expected to rise at a CAGR of 6.0% during the projected period. The market value is set to increase from US$ 512.0 million in 2024 to US$ 872.9 million in 2034.
Vitamin Biomarkers Market: Size is projected to be worth US$ 3.2 billion in 2023. The market is likely to surpass US$ 9.8 billion by 2033 at a CAGR of 11.9% during the forecast period. The market for vitamin biomarkers has been experiencing significant growth and is expected to continue expanding.
Vitamin D Testing Market: Size is anticipated to be US$ 917.55 million in 2023. According to Future Market Insights, the market is projected to expand at a significant CAGR of 8.1% and reach US$ 1,999.35 million by 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vasat team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact FMI:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
